Second-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland

Simpson, C R, Kerr, S, Katikireddi, S V, McCowan, C, Ritchie, L D, Pan, J, Stock, S J, Rudan, I, Tsang, R S M, de Lusignan, S, Hobbs, F D R, Akbari, A, Lyons, R A, Robertson, C & Sheikh, A 2022, 'Second-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland', Nature Communications, vol. 13, 4800. https://doi.org/10.1038/s41467-022-32264-6